SPARC (osteonectin/BM-40).
SPARC (Secreted ProteinAcidic and Rich in Cysteine) is a prototype of a family of biologically active glycoproteins that bind to cells and to extracellular matrix (ECM) components. It is expressed spatially and temporally during embryogenesis, tissue remodeling and repair. SPARC is a modular protein (34 kDa) comprised of three structural domains, one or more of which are implicated in the regulation of cell adhesion, proliferation, matrix synthesis/turnover. Rapid proteolysis of SPARC by extracellular proteases accounts for its transient detection in the extracellular environment. The proposed roles of SPARC in the development of cataracts and the regulation of angiogenesis during wound healing and tumor growth account for the recent attention it has received from the biomedical community.
Motamed
K
K
Department of Vascular Biology, The Hope Heart Institute, Seattle, WA 98122, USA. kmotamed@providence.org
D000818:Animals; D005314:Embryonic and Fetal Development; D005109:Extracellular Matrix / Q000502:physiology*; D006801:Humans; D009369:Neoplasms / Q000473:pathology / Q000503:physiopathology; D015676:Osteonectin / Q000737:chemistry / Q000235:genetics / Q000502:physiology*
D015676:Osteonectin